Transchem Limited Completes MOA Alteration Following Rs. 461.25 Crore Warrant Approval

2 min read     Updated on 21 Nov 2025, 05:49 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Transchem Limited has successfully completed its capital restructuring plan by formally altering its MOA following unanimous shareholder approval at the EGM held on December 20, 2025. The company increased its authorized share capital from Rs. 30 crore to Rs. 75 crore and approved the issuance of 6.15 crore warrants worth Rs. 461.25 crore to strategic investors including Bakkt Opco Holdings LLC.

25273149

*this image is generated using AI for illustrative purposes only.

Transchem Limited has successfully completed its strategic capital restructuring plan after shareholders unanimously approved all proposed resolutions at the Extraordinary General Meeting (EGM) held on December 20, 2025. The company has now formally altered its Memorandum of Association (MOA) to implement the approved capital structure changes, as announced on December 22, 2025.

EGM Voting Results - Complete Approval

All three resolutions presented at the EGM received unanimous approval from shareholders, demonstrating strong confidence in the company's strategic direction:

Resolution: Description Votes in Favor Votes Against Approval Rate
Resolution 1 Increase in Authorized Share Capital 84,94,965 1 100.00%
Resolution 2 Authorization under Section 186 84,94,965 1 100.00%
Resolution 3 Warrant Issue on Preferential Basis 84,94,965 1 100.00%

The voting was conducted through remote e-voting from December 17-19, 2025, and electronic voting during the EGM held via video conferencing.

Formal MOA Alteration Completed

Following the EGM approval, Transchem Limited has formally altered its Memorandum of Association by substituting the existing Clause 5 with a new capital clause. The updated MOA now reflects:

Parameter: Previous Structure New Structure
Authorized Capital Rs. 30.00 crore Rs. 75.00 crore
Number of Shares 3.00 crore 7.50 crore
Face Value per Share Rs. 10.00 Rs. 10.00

The alteration provides the company with enhanced flexibility to increase, reduce, consolidate, or subdivide capital and create different share classes with varying rights and privileges as permitted under the Companies Act, 2013.

Approved Warrant Issue Structure

With the MOA alteration completed, the company can now proceed with the issuance of up to 6.15 crore warrants, each convertible into one equity share, raising up to Rs. 461.25 crore at Rs. 75.00 per warrant:

Allottee: Number of Warrants Post-Conversion Shareholding
Bakkt Opco Holdings LLC 4,75,00,000 64.42%
Mr. Pishu Chainani 1,20,00,000 16.27%
JVS Holdings LLP 16,00,000 2.17%
Mr. Dhawal Mehta 4,00,000 0.54%
Total 6,15,00,000 83.40%

Enhanced Financial Authority

Shareholders have also approved increasing the company's authority for making investments, providing loans, or offering guarantees to Rs. 250.00 crore, significantly enhancing Transchem's financial flexibility and investment capabilities.

Implementation Timeline

With both shareholder approval and MOA alteration completed, the warrants will carry an 18-month exercise period from allotment date. Following SEBI regulations, allottees must pay 25% consideration upfront, with the remaining 75% due upon warrant conversion to equity shares.

The completion of MOA alteration marks the final procedural step in Transchem Limited's capital restructuring journey, setting the foundation for significant changes in ownership structure and enhanced financial capabilities. The company can now proceed with regulatory approvals and implementation of these strategic initiatives.

Historical Stock Returns for Transchem

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%-11.35%+10.51%+323.20%+287.05%+789.92%
Transchem
View in Depthredirect
like19
dislike

Transchem Reports Strong Q2 FY2026 Results, Plans Strategic Acquisition

1 min read     Updated on 16 Oct 2025, 06:33 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Transchem announced robust Q2 and H1 FY2026 results, with Q2 net profit at ₹67.92 crores and H1 net profit at ₹167.25 crores. The company plans to acquire 100% equity in Greshma Shares & Stocks Limited (GSSL), a stock broking and financial services firm. The acquisition, subject to approvals, will diversify Transchem's portfolio into financial services. GSSL reported an annual turnover of ₹11.32 crores and net worth of ₹15.89 crores as of March 2025. Transchem also adopted new Articles of Association and amended its Memorandum of Association.

22165392

*this image is generated using AI for illustrative purposes only.

Transchem has announced robust financial results for the second quarter and first half of fiscal year 2026, along with plans for a significant acquisition in the financial services sector.

Financial Performance

The company's Board of Directors approved the unaudited financial results for Q2 and H1 FY2026, revealing impressive growth:

Period Net Profit (₹ in crores)
Q2 FY2026 67.92
H1 FY2026 167.25

Strategic Acquisition

In a move to diversify its business portfolio, Transchem has granted in-principle approval to acquire 100% equity in Greshma Shares & Stocks Limited (GSSL), a stock broking and financial services company. Key details of the proposed acquisition include:

  • Acquisition Target: Greshma Shares & Stocks Limited
  • Equity Stake: 100%
  • Shares to be Acquired: 1,55,16,000
  • GSSL Financials (as of March 2025):
    • Annual Turnover: ₹11.32 crores
    • Net Worth: ₹15.89 crores

The acquisition is subject to due diligence and regulatory approvals from SEBI, stock exchanges, and depositories. Upon completion, GSSL would become a wholly-owned subsidiary of Transchem.

Strategic Implications

This acquisition marks Transchem's entry into the comprehensive financial services sector. The move is expected to:

  1. Diversify Transchem's business portfolio
  2. Leverage GSSL's platform for stock broking and wealth management
  3. Expand service offerings to include equity and derivatives trading on BSE and NSE

Timeline and Process

  • The acquisition process is expected to be completed within 3 months of entering the non-binding term sheet.
  • The transaction will be an all-cash deal, with the final price to be determined after due diligence.

Corporate Actions

In addition to the financial results and acquisition plans, Transchem has taken significant corporate actions:

  1. Articles of Association: The company has adopted a new set of Articles of Association in conformity with the Companies Act, 2013.
  2. Memorandum of Association: Amendments to the Memorandum of Association have been approved.

These changes were passed as Special Resolutions at the company's Extra-Ordinary General Meeting held on October 16, 2025.

Transchem's strategic moves and strong financial performance indicate a positive outlook for the company as it expands its footprint in the financial services sector.

Historical Stock Returns for Transchem

1 Day5 Days1 Month6 Months1 Year5 Years
-1.99%-11.35%+10.51%+323.20%+287.05%+789.92%
Transchem
View in Depthredirect
like17
dislike
More News on Transchem
Explore Other Articles
172.20
-3.50
(-1.99%)